Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionVPACX - Vanguard Pacific Stock Index Fund Investor Shares
Latest Disclosed Ownership30,130 shares
Latest Disclosed Value $ 241,579
VPACX - Vanguard Pacific Stock Index Fund Investor Shares ownership in 4577 / Daito Pharmaceutical Co.,Ltd.

On June 26, 2026 - VPACX - Vanguard Pacific Stock Index Fund Investor Shares filed a NPORT-P form disclosing ownership of 30,130 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $37,993,930 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 31, 2026 disclosing 30,130 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $40,856,280 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-26 2026-04-30 NP DAITO PHARMA EC JP3486150000 30,130 0 0.00 242 -7.31 0.0018
2026-03-31 2026-01-31 NP DAITO PHARMA EC JP3486150000 30,130 0 0.00 260 7.00 0.0019
2025-12-23 2025-10-31 NP DAITO PHARMA EC JP3486150000 30,130 0 0.00 243 1.25 0.0020
2025-09-25 2025-07-31 NP DAITO PHARMA EC JP3486150000 30,130 10,715 55.19 241 -15.19 0.0023
2025-06-30 2025-04-30 NP DAITO PHARMA EC JP3486150000 19,415 0 0.00 283 9.27 0.0028
2025-03-31 2025-01-31 NP DAITO PHARMA EC JP3486150000 19,415 0 0.00 259 -8.48 0.0027
2024-12-27 2024-10-31 NP DAITO PHARMA EC JP3486150000 19,415 0 0.00 284 -8.71 0.0029
2024-09-27 2024-07-31 NP DAITO PHARMA EC JP3486150000 19,415 0 0.00 310 0.32 0.0030
2024-06-27 2024-04-30 NP DAITO PHARMA EC JP3486150000 19,415 0 0.00 310 19.31 0.0032
2024-04-01 2024-01-31 NP DAITO PHARMA EC JP3486150000 19,415 0 0.00 259 4.44 0.0027
2023-12-28 2023-10-31 NP DAITO PHARMA EC JP3486150000 19,415 1,765 10.00 248 -14.48 0.0028
2023-09-29 2023-07-31 NP DAITO PHARMA EC JP3486150000 17,650 0 0.00 291 -11.59 0.0030
2023-06-29 2023-04-30 NP DAITO PHARMA EC JP3486150000 17,650 0 0.00 329 -8.12 0.0037
2023-03-31 2023-01-31 NP DAITO PHARMA EC JP3486150000 17,650 0 0.00 357 17.82 0.0039
2022-12-28 2022-10-31 NP DAITO PHARMA EC JP3486150000 17,650 0 0.00 304 -13.43 0.0040
2022-09-29 2022-07-31 NP DAITO PHARMA EC JP3486150000 17,650 0 0.00 351 -0.85 0.0041
2022-06-29 2022-04-30 NP DAITO PHARMA EC JP3486150000 17,650 0 0.00 353 -17.52 0.0045
2022-04-01 2022-01-31 NP DAITO PHARMA EC JP3486150000 17,650 7,600 75.62 428 51.24 0.0049
2021-12-30 2021-10-31 NP DAITO PHARMA EC JP3486150000 10,050 0 0.00 283 -7.21 0.0032
2021-09-29 2021-07-31 NP DAITO PHARMA EC JP3486150000 10,050 0 0.00 305 -4.09 0.0035
2021-06-29 2021-04-30 NP DAITO PHARMA EC JP3486150000 10,050 0 0.00 319 -10.42 0.0037
2021-04-01 2021-01-31 NP DAITO PHARMA EC JP3486150000 10,050 0 0.00 356 -7.31 0.0044
2020-12-29 2020-10-31 NP DAITO PHARMA EC JP3486150000 10,050 0 0.00 384 28.52 0.0061
2020-09-29 2020-07-31 NP DAITO PHARMA EC JP3486150000 10,050 0 0.00 298 -7.74 0.0049
2020-03-31 2020-01-31 NP Daito Pharmaceutical Co. EC JP3486150000 10,050 0 0.00 324 6.95 0.0049
2019-12-30 2019-10-31 NP Daito Pharmaceutical Co. EC JP3486150000 10,050 10,050 303 0.0045
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.